KYNB
Kyntra Bio
KYNB
KYNB
118 hedge funds and large institutions have $627M invested in Kyntra Bio in 2015 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 46 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
6% more capital invested
Capital invested by funds: $593M → $627M (+$34.2M)
3% less call options, than puts
Call options by funds: $2.17M | Put options by funds: $2.25M
Holders
118
Holding in Top 10
3
Calls
$2.17M
Puts
$2.25M
Top Buyers
| 1 | +$23.2M | |
| 2 | +$19M | |
| 3 | +$10.7M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$9.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.3M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$5.79M | |
| 3 | -$5.38M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.45M |
| 5 |
Lazard Asset Management
New York
|
-$4.21M |